U.S. Presidential candidate Elizabeth Warren along with fellow Senators Richard Blumenthal and Bill Cassidy wrote a letter to Alphabet’s Google to raise questions about the company’s access to the health records of tens of millions of Americans.
Special Feature — Agenda 2016: Bigger, better, faster, more
ACA, Agenda Special Feature, Big Data, Biosimilars, Data, FDA, FDA/Regulatory, February 2016, Healthcare, Healthcare Communications Agencies, Issue Archives, Managed Care, Marketing & Advertising, Presidential Candidates, Price Controls, Price Hikes, Pricing, Social Media, Technology, WearablesOr, why 2016 might look a little different than 2015 for pharmaceutical marketers.
The CHC’s mission is to promote and protect the benefit, for society and individual patient care, of the free flow of healthcare information.
Healthcare Agency Roundtable 2015
21st Century Cures Act, ACA, Affordable Care Act, Approvals, Biosimilars, December 2015, Digital, Digital Marketing, DTC, FDA, FDA/Regulatory, Generics, Healthcare, Healthcare Communications Agencies, Healthcare Physicians, Healthcare Practitioners, Healthcare Providers, Healthcare/Medicare/Medicaid, Issue Archives, Launches, Legislation, Marketing & Advertising, New Molecular Entities, Patient Outcomes, Politics, Presidential Candidates, Price Gouging, Price Hikes, Pricing, Product Launches, Retail Pharmaceuticals, Special Reports, Technology, WearablesExecutives from the 2015 and 2014 Manny Award winners and finalists share their views on a variety of industry-related topics.
The debate in Washington over drug pricing is getting louder and nastier, and drug marketing is getting caught in the crossfire.
Sales and Marketing: Drug costs top public priority list for healthcare: KFF
ACA, Affordable Care Act, December 2015, DTC, FDA, FDA/Regulatory, Healthcare, Healthcare/Medicare/Medicaid, Hepatitis, HIV, HIV, Issue Archives, Mental Health Disorders, Oncology, Politics, Polls, Presidential Candidates, Price Hikes, PricingWith presidential primaries right around the corner, the cost of prescription drugs is at the top of the public’s healthcare priority list for the President and Congress, according to polling data from the Kaiser Family Foundation.